• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Global expansion of China National Tobacco Corporation and its implications for international tobacco control

Objective

To examine the potential implications and challenges posed by the global expansion of China National Tobacco Corporation (CNTC) for global tobacco control efforts.

Methods

We used publicly available financial and operational data from 2021 to 2023 of CNTC and four major transnational tobacco companies—Philip Morris International, British American Tobacco, Japan Tobacco International and Imperial Brands—to assess company performance across six dimensions: enterprise scale, cost efficiency, tax exposure, profitability, market presence, investment in technological innovation and product diversification.

Results

CNTC operates at larger scale than its international counterparts, with higher total assets, production and profits, alongside a lower liability-to-asset ratio and a higher effective corporate tax burden. However, CNTC exhibits limited diversification into non-combustible products and lower research and development investment than transnational tobacco companies. CNTC’s large-scale production and growing overseas footprint may enable lower pricing in global markets, particularly in low- and middle-income countries, with potential consequences for global tobacco control.

Conclusions

CNTC’s international expansion brings significant but under-recognised risk to global tobacco control efforts. CNTC’s large scale and financial structure enable robust capacity to influence international tobacco markets in ways that may undermine taxation, regulation and public health objectives. Stronger international coordination as well as enhanced fiscal and regulatory tools are essential to protect global tobacco control efforts.

Read the full article ›

Posted in: Journal Article Abstracts on 02/05/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice